Atrás
72
88
72
62
Rango del Día
$97.45
$102.01
Rango de 52 Semanas
$45.88
$193.07
Volumen
104,886
Promedio 50D / 200D
$122.92
/
$118.80
Cierre Anterior
$99.49
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 8.4 | 0.2 |
| P/B | 1.8 | 3.0 |
| ROE % | 29.8 | 3.6 |
| Net Margin % | 8.1 | 3.8 |
| Rev Growth 5Y % | 27.5 | 9.9 |
| D/E | 1.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$205.00
+104.2%
P/E Futuro
6.51
EPS Futuro
$15.41
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
910.48M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$17.56
$16.79 – $18.62
|
947.42M | 1 |
| FY2026 |
$15.41
$14.74 – $16.35
|
910.48M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-05 | $5.56 | $1.61 | -71.0% |
| 2025-11-19 | $1.81 | $7.76 | +328.7% |
| 2025-10-08 | -$5.43 | -$3.02 | +44.3% |
| 2025-05-13 | $2.29 | $2.56 | +11.8% |
| 2025-03-31 | -$0.12 | $11.12 | +9366.7% |
| 2024-11-08 | -$0.24 | -$1.72 | -616.7% |
| 2024-08-08 | -$0.29 | -$0.07 | +75.9% |
| 2024-05-08 | N/A | -$0.10 | — |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Revenue grew 27.47% annually over 5 years — strong growth
Earnings grew 35.67% over the past year
ROE of 29.76% indicates high profitability
Generating 245.60M in free cash flow
P/E of 8.44 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 54.89%
Crecimiento
Revenue Growth (5Y)
27.47%
Revenue (1Y)82.36%
Earnings (1Y)35.67%
FCF Growth (3Y)N/A
Calidad
Return on Equity
29.76%
ROIC30.36%
Net Margin8.09%
Op. Margin31.49%
Seguridad
Debt / Equity
1.07
Current Ratio3.41
Interest Coverage12.40
Valoración
P/E Ratio
8.44
Forward P/E6.51
P/B Ratio1.81
EV/EBITDA2.77
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 82.36% | Revenue Growth (3Y) | 88.00% |
| Earnings Growth (1Y) | 35.67% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 27.47% | Earnings Growth (5Y) | -14.52% |
| Profitability | |||
| Revenue (TTM) | 875.26M | Net Income (TTM) | 70.79M |
| ROE | 29.76% | ROA | 7.71% |
| Gross Margin | 50.76% | Operating Margin | 31.49% |
| Net Margin | 8.09% | Free Cash Flow (TTM) | 245.60M |
| ROIC | 30.36% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.07 | Current Ratio | 3.41 |
| Interest Coverage | 12.40 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 8.44 | Forward P/E | 6.51 |
| P/B Ratio | 1.81 | P/S Ratio | 0.68 |
| PEG Ratio | 1.77 | Forward PEG | N/A |
| EV/EBITDA | 2.77 | Fwd EV/EBITDA | 29.42 |
| Forward P/S | 0.66 | Fwd Earnings Yield | 15.36% |
| FCF Yield | 41.09% | ||
| Market Cap | 597.70M | Enterprise Value | 763.51M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 875.26M | 479.95M | 247.65M | 219.29M | 331.53M |
| Net Income | 70.79M | 52.18M | -45.79M | -424.78M | 132.59M |
| EPS (Diluted) | 10.48 | 9.71 | -10.39 | -100.36 | 33.55 |
| Gross Profit | 444.28M | 196.26M | 34.77M | 15.42M | 179.28M |
| Operating Income | 275.63M | 130.62M | -31.77M | -406.60M | 170.26M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 918.53M | 655.32M | 398.25M | 431.75M | 394.65M |
| Total Liabilities | 495.09M | 453.43M | 319.14M | 311.42M | 203.07M |
| Shareholders' Equity | 329.45M | 146.34M | 61.45M | 95.86M | 114.65M |
| Total Debt | 351.39M | 340.30M | 275.76M | 267.20M | 178.55M |
| Cash & Equivalents | 185.57M | 43.58M | 22.00M | 34.26M | 36.12M |
| Current Assets | 538.81M | 292.48M | 90.85M | 97.97M | 154.02M |
| Current Liabilities | 157.91M | 140.87M | 58.31M | 54.86M | 37.69M |
Puntuaciones de Estrategias
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#90 of 1049
#20 of 619
#44 of 158
Custom
Full Throttle
#26 of 148
Actividad Reciente
Salió
Contrarian Investing (David Dreman)
Mar 26, 2026
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entró
Contrarian Investing (David Dreman)
Mar 24, 2026
Entró
Growth Investing (Philip Fisher)
Mar 24, 2026
Entró
Full Throttle
Mar 24, 2026